BSX Stock Analysis: Boston Scientific Corp
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary a
- Latest close
- $42.4
- 20-day change
- -11.30%
- Trend state
- LEAN BEAR
- Classification
- Healthcare · Medical - Devices
Market context
Boston Scientific Corp moved -11.30% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BEAR.
Latest report
The latest cached company filing period (FY2025 · $20.1B revenue · $2.9B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Quality is currently the strongest dimension at 5.3/6, while Future is the lowest at 4.3/6. Scores are comparative research signals, not forecasts.